Vyome Holdings, Inc.
HIND
Rank in Stocks
#28297
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical... Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
Share Price
$1.63
Last synced: 2026-11-12
Market Cap
$11.44M
Change (1 day)
3.82%
Change (1 year)
-66.94%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Vyome Holdings, Inc. (HIND)
Category
Healthcare
EPS for Vyome Holdings, Inc. (HIND)
EPS as of June 2026 TTM: $-29.90
According to Vyome Holdings, Inc.'s latest financial reports, its current EPS (TTM) is $-29.90. At the end of 2025 the company had an EPS of $-4.75, an increase over its 2024 EPS of $-345.74.
EPS history for Vyome Holdings, Inc. from 2003 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-29.90 | 529.47% |
| 2025 | $-4.75 | -98.63% |
| 2024 | $-345.74 | -87.53% |
| 2023 | $-2.77K | -98.24% |
| 2022 | $-157.90K | -62.32% |
| 2021 | $-419.00K | -16.70% |
| 2020 | $-503.02K | -54.02% |
| 2019 | $-1.09M | -74.38% |
| 2018 | $-4.27M | -5.60% |
| 2017 | $-4.52M | -57.11% |
| 2016 | $-10.55M | 420.74% |
| 2015 | $-2.03M | 57.30% |
| 2014 | $-1.29M | 0.00% |
| 2013 | 0.00 | -100.00% |
| 2012 | $-1.72K | -31.05% |
| 2011 | $-2.50K | -58.23% |
| 2010 | $-5.98K | -67.90% |
| 2009 | $-18.61K | 185.33% |
| 2008 | $-6.52K | -80.75% |
| 2007 | $-33.89K | -65.81% |
| 2006 | $-99.14K | 18.61% |
| 2005 | $-83.59K | 18.30% |
| 2004 | $-70.66K | 103.78% |
| 2003 | $-34.67K | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -152.37% |
US
|
|
| $-7.07 | -76.35% |
US
|
|
| $-5.29 | -82.31% |
AU
|
|
| $12.88 | -143.08% |
BE
|
|
| $21.56 | -172.11% |
NL
|
Questions about Vyome Holdings, Inc.'s earnings per share (EPS)
What is Vyome Holdings, Inc.'s earnings per share (EPS)?
Vyome Holdings, Inc.'s earnings per share (EPS) over the last twelve months is $-29.90, as of Jun 2026.
What was Vyome Holdings, Inc.'s earnings per share (EPS) in 2025?
In 2025, Vyome Holdings, Inc.'s earnings per share (EPS) was $-4.75, compared with $-345.74 in 2024.
How has Vyome Holdings, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Vyome Holdings, Inc.'s earnings per share (EPS) was highest in 2025 ($-4.75) and lowest in 2020 ($-503.02K).
How does Vyome Holdings, Inc.'s earnings per share (EPS) compare with similar companies?
Vyome Holdings, Inc.'s earnings per share (EPS) ($-29.90) is lower than that of all 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.